注射用双黄连冻干粉治疗上呼吸道感染98例临床剖析.docVIP

  • 12
  • 0
  • 约3.42千字
  • 约 7页
  • 2018-11-16 发布于福建
  • 举报

注射用双黄连冻干粉治疗上呼吸道感染98例临床剖析.doc

注射用双黄连冻干粉治疗上呼吸道感染98例临床剖析

注射用双黄连冻干粉治疗上呼吸道感染98例临床剖析   [摘要] 目的:观察注射用双黄连冻干粉治疗上呼吸道感染的临床疗效。方法:将178例患者随机分为两组,治疗组98例采用注射用双黄连冻干粉治疗,对照组80例采用病毒唑注射液治疗,比较两组临床疗效。结果:治疗组总有效率为94.9%,对照组总有效率为82.5%,两组比较差异有统计学意义(P<0.05)。结论:双黄连冻干粉治疗上呼吸道感染有较好的临床疗效。   [关键词] 上呼吸道感染;中药治疗;注射用双黄连冻干粉;临床应用   [中图分类号]R56[文献标识码]B[文章编号]1673-7211(2008)11(a)-074-02      Treatment of 98 cases of upper respiration infection with Shuanghuanglian Lyophilized Powder for injection   OUYANG Jin, LI Wei, TANG Rui-xian   (Outpatient Department, Jilin Medical College, Jilin132013,China)   [Abstract] Objective: To investigate clinical efficiency of Shuanghuanglian Lyophilized Powder for injection in the treatment of upper respiratory tract infection. Methods: 178 cases were divided into two groups. 98 cases of the treatment group used Shuanghuanglian Lyophilized Powder for injection, meanwhile, in the control group of 80 cases using ribavirin injection treatment.Clinical compared between the two groups. Results: The total efficiency was 94.9% for the treatment group and the control group was 82.5%.Difference between the two groups is statistically significant (P<0.05). Conclusion: Shuanghuanglian Lyophilized Powder for injection which is used for the treatment of upper respiratory tract infection has better clinical efficacy.   [Key words] Upper respiratory tract infection; Chinese medicine therapy; Shuanghuanglian Lyophilized Powder for injection; Clinical application      注射用双黄连冻干粉是一种纯中药制剂,具有表里双解、清热解毒、气血两清的功效,用于外感风热、温病初起及多种温热病的实热症等。2007年2~12月,笔者应用注射用双黄连冻干粉治疗急性上呼吸道感染患者98例,取得较好疗效,现报道如下:   1 资料与方法   1.1 一般资料   178例患者均系我院门诊或住院患者,随机分为两组。治疗组98例,其中,男性43例,女性55例;年龄14~88岁,平均(27.9±5.5)岁;急性支气管炎24例,急性扁桃体炎13例,急性咽喉炎19例,普通感冒42例;发病时间1 h~4 d,平均31.6 h。初诊体温37.0~37.9℃者35例,38.0~38.9℃者38例,39℃及以上者25例。实验室检查:血白细胞计数<10.1×109/L者55例,≥10.1×109/L者43例;中性粒细胞比例<0.70者42例,≥0.70者56例。对照组80例,其中,男性35例,女性45例;年龄13~80岁,平均(30.0±6.5)岁;急性支气管炎16例,急性扁桃体炎11例,急性咽喉炎21例,普通感冒32例;发病时间1 h~4 d,平均29.9 h。两组性别、年龄、病程及症状分布经统计学分析,无显著性差异(P>0.05),具有可比性。   1.2 诊断标准   参照全国高等医药院校教材《内科学》[1] 、人民军医出版社《

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档